Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polyamine binding sites on polyamine-regulated proteins are critical regulatory regions found on a variety of proteins, including ion channels, enzymes, and translation factors. These sites interact with endogenous polyamines like putrescine, spermidine, and spermine to modulate essential cellular processes such as gene expression, protein synthesis, and ion flux (Igarashi, K., & Kashiwagi, K., 2010, The International Journal of Biochemistry & Cell Biology). In ion channels, such as NMDA receptors and inward-rectifier potassium (Kir) channels, polyamines act as voltage-dependent blockers, thereby regulating neuronal excitability and cardiac function (Williams, K., 1997, Biochemical Journal). Polyamines also play a pivotal role in cancer biology, where they are often found at elevated levels to support rapid cell proliferation and survival (Casero, R. A., et al., 2018, Nature Reviews Cancer). Therapeutic targeting of these sites involves the use of polyamine analogs or inhibitors of polyamine biosynthesis, such as eflornithine, which is used to treat neuroblastoma and African trypanosomiasis (Pegg, A. E., 2016, Journal of Biological Chemistry). Additionally, drugs like memantine and ifenprodil target polyamine-sensitive sites on NMDA receptors to treat neurodegenerative conditions like Alzheimer's disease. Because polyamines are ubiquitous and involved in many housekeeping functions, drugs targeting these sites must be carefully designed to avoid systemic toxicities like ototoxicity or gastrointestinal distress.
Modulation of ion channel conductance through pore blocking, competitive inhibition of polyamine biosynthetic enzymes, and induction of feedback degradation pathways via polyamine analogs.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polyamine binding sites on polyamine-regulated proteins.